AbbVie Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (134)

View All

Latest Posts

About This Stock More About This Stock
June 2019 Stock Considerations
Article By: Keith Park
Wednesday, June 12, 2019 4:10 AM EDT
After a wild May, we seem to be trending back up in June.
In this article: MO, PM, GILD, ABBV
Read
E AbbVie: This High-Yield Dividend Aristocrat Is A Buy
Article By: SureDividend
Monday, June 10, 2019 8:03 PM EDT
AbbVie stock has significantly underperformed the broader S&P Index this year, but the stock could be a bargain and an attractive buying opportunity for long-term dividend growth.
In this article: ABBV
Read
E Portfolio Highlights - June 2019
Article By: Ingrid Hendershot
Wednesday, June 5, 2019 3:13 PM EDT
During the past three months, the S&P 500 Index rose 2.6% despite renewed concerns over a trade war. The following high-quality stocks all generated double-digit gains during the same period.
In this article: FDS, FB, MSFT, PAYX, MA, CSCO, PEP, ABBV, ROST, WBA, FFIV, GNTX, GPC, MMS
Read
Dividend Income Update May 2019
Article By: Andreas Gruener
Sunday, June 2, 2019 9:13 PM EDT
Time for one of my favorite posts of each month: the dividend income update. It is now already June, one of the strongest dividend months of the year. But May was not so for us either...
In this article: PG, VZ, T, ABBV, GIS, HRL, BASFY, DDAIF, MURGY, VE
Read
Is AbbVie Stock A Buy In May 2019?
Article By: SureDividend
Saturday, May 25, 2019 2:00 PM EDT
Volatility has returned to the stock market, as a result of escalating trade tensions. During periods of heightened geopolitical risk, it is a good time for investors to refocus on high-quality dividend growth stocks.
In this article: ABBV Also: ABT
Read
All Posts

PARTNER HEADLINES

Latest Tweets for $ABBV

No tweets yet!

$ABBV

Comments Status Updates
AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug
Bruce Powers • 1/23/2017 6:21:09 PM

Excited to hear the #FDA approved #IMBRUVICA. Should bode very well for $ABBV. And I think it's 8% price hike of #Humira is reasonable (though I realize those taking the drug may disagree).

1 to 1 of 1 comments